Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,052 | 17,171 | 193,650 | 205,530 | 191,859 |
| Marketable Securities | 62,571 | 157,338 | N/A | 99,696 | 124,260 |
| Receivables | 3,103 | 3,432 | 35,986 | 790 | 798 |
| TOTAL | $107,305 | $182,936 | $237,102 | $310,301 | $324,013 |
| Non-Current Assets | |||||
| PPE Net | 2,467 | 3,958 | 5,072 | 5,960 | 6,950 |
| Intangibles | 1,532 | 1,678 | 1,824 | 1,970 | 2,116 |
| Other Non-Current Assets | 9,229 | 13,220 | 16,893 | 21,180 | 25,584 |
| TOTAL | $13,228 | $18,856 | $23,789 | $29,110 | $34,650 |
| Total Assets | $120,533 | $201,792 | $260,891 | $339,411 | $358,663 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 4,082 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,088 | 1,458 | 2,809 | 2,818 | 2,996 |
| Accrued Expenses | 12,338 | 17,599 | 24,450 | 34,236 | 23,059 |
| TOTAL | $85,772 | $155,913 | $152,608 | $77,870 | $100,924 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 67,201 | 132,267 | 121,267 | 40,816 | 74,869 |
| Other Non-Current Liabilities | 8,355 | 13,278 | 13,975 | 18,056 | 21,675 |
| TOTAL | $35,217 | $93,326 | $194,034 | $262,000 | $207,936 |
| Total Liabilities | $120,989 | $249,239 | $346,642 | $339,870 | $308,860 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 80,100 | 67,722 | 66,228 | 65,393 | 64,784 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -691,579 | -723,448 | -722,879 | -623,562 | -450,115 |
| Other shareholders' equity | 27 | 95 | 10 | -242 | -47 |
| TOTAL | $-456 | $-47,447 | $-85,751 | $-459 | $49,803 |
| Total Liabilities And Equity | $120,533 | $201,792 | $260,891 | $339,411 | $358,663 |